DE60104283D1 - Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren - Google Patents

Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren

Info

Publication number
DE60104283D1
DE60104283D1 DE60104283T DE60104283T DE60104283D1 DE 60104283 D1 DE60104283 D1 DE 60104283D1 DE 60104283 T DE60104283 T DE 60104283T DE 60104283 T DE60104283 T DE 60104283T DE 60104283 D1 DE60104283 D1 DE 60104283D1
Authority
DE
Germany
Prior art keywords
pyrimidine
domestic
farm animals
endotheline antagonists
endotheline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60104283T
Other languages
English (en)
Other versions
DE60104283T2 (de
Inventor
Bernard J Banks
Adrian P Foster
Stephen P Gibson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE60104283D1 publication Critical patent/DE60104283D1/de
Application granted granted Critical
Publication of DE60104283T2 publication Critical patent/DE60104283T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)
DE2001604283 2000-02-11 2001-02-06 Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren Expired - Fee Related DE60104283T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0003234 2000-02-11
GBGB0003234.2A GB0003234D0 (en) 2000-02-11 2000-02-11 Method of treatment
PCT/IB2001/000142 WO2001058882A1 (en) 2000-02-11 2001-02-06 Use of pyrimidine endothelin antagonists in companion animals

Publications (2)

Publication Number Publication Date
DE60104283D1 true DE60104283D1 (de) 2004-08-19
DE60104283T2 DE60104283T2 (de) 2004-11-18

Family

ID=9885465

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2001604283 Expired - Fee Related DE60104283T2 (de) 2000-02-11 2001-02-06 Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren

Country Status (17)

Country Link
EP (1) EP1254120B1 (de)
JP (1) JP2003528050A (de)
KR (1) KR20020075791A (de)
AT (1) ATE271042T1 (de)
AU (1) AU3043601A (de)
CA (1) CA2398007A1 (de)
DE (1) DE60104283T2 (de)
DK (1) DK1254120T3 (de)
ES (1) ES2222975T3 (de)
GB (1) GB0003234D0 (de)
HU (1) HUP0204370A3 (de)
IL (1) IL150488A0 (de)
NZ (1) NZ519002A (de)
PT (1) PT1254120E (de)
TR (1) TR200401815T4 (de)
WO (1) WO2001058882A1 (de)
ZA (1) ZA200206343B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8647660B2 (en) 2004-12-29 2014-02-11 Hill's Pet Nutrition, Inc. Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health
JP5451065B2 (ja) * 2005-04-19 2014-03-26 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 腎疾患の予防および治療のための方法および組成物
CN102770195B (zh) * 2010-02-25 2015-03-04 弗·哈夫曼-拉罗切有限公司 高亲和性化合物结合常数的测定方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE201202T1 (de) * 1995-12-20 2001-06-15 Yamanouchi Pharma Co Ltd Arylethensulfonamid-derivate und diese enthaltende medikamente
WO1998057938A1 (fr) * 1997-06-19 1998-12-23 Yamanouchi Pharmaceutical Co., Ltd. Derives d'alcanesulfonamide inferieur substitue et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
AU3043601A (en) 2001-08-20
HUP0204370A3 (en) 2003-07-28
PT1254120E (pt) 2004-10-29
ES2222975T3 (es) 2005-02-16
HUP0204370A2 (en) 2003-05-28
IL150488A0 (en) 2002-12-01
TR200401815T4 (tr) 2004-08-23
ZA200206343B (en) 2003-08-08
ATE271042T1 (de) 2004-07-15
WO2001058882A1 (en) 2001-08-16
KR20020075791A (ko) 2002-10-05
EP1254120B1 (de) 2004-07-14
CA2398007A1 (en) 2001-08-16
NZ519002A (en) 2004-06-25
GB0003234D0 (en) 2000-04-05
DK1254120T3 (da) 2004-10-04
JP2003528050A (ja) 2003-09-24
DE60104283T2 (de) 2004-11-18
EP1254120A1 (de) 2002-11-06

Similar Documents

Publication Publication Date Title
EA200100058A1 (ru) 4-бензилпиперидиналкилсульфоксидные гетероциклические соединения и их применение в качестве подтип-избирательных антагонистов nmda-рецепторов
EA200401284A1 (ru) Замещённые бензазолы и их применение в качестве ингибиторов киназы raf
EA200201119A1 (ru) Лиганды меланокортиновых рецепторов
TR200100917T2 (tr) Aril ve heteroaril sübstitüentli heteroksiklik üreler kullanılarak RAF kinazın inhibe edilmesi
TR200002616T2 (tr) Simetrik ve simetrik olmayan sübstitüe edilmiş difenil üreler kullanılarak raf kinazın inhibe edilmesi
EA200500520A1 (ru) Пуриновые соединения и их применение в качестве лигандов каннабиноидных рецепторов
BR0317096A (pt) Compostos de pirazol e imidazol e suas utilizações
ATE362473T1 (de) 1,5-disubstituierte 3,4-dihydro-1h-4,5- döpyrimidin-2-on-verbindungen und ihre verwendung in der behandlung von durch csbp/p38 kinase beeinflussten krankheiten
NL300149I1 (nl) Samenstelling met insecticide werking tegen vlooien bij zoogdieren, in het bijzonder honden en katten.
TR200402577T4 (tr) Urasil bileşikleri ve bunların kullanımları
ATE481103T1 (de) Derivate von 2-(8,9-dioxo-2,6- diazabicyclo(5.2.0)non-1(7)-en-2- yl)alkylphosphonsäure und deren verwendung als n- methyl-d-aspartat- (nmda-) rezeptorantagonisten
PT1176875E (pt) Utilizacao da cretina como aditivo de forragens
HN2004000023A (es) Mascadura para animales
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
BR9909408A (pt) Tratamento de animais com compostos de diidroxiquinolina
MXPA03011630A (es) Compuestos de amenoacetonitrilo para el control de endoparasitos.
DE60104283D1 (de) Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren
ATE31306T1 (de) Chinazolinon-derivate wirksam gegen coccidiosis.
BR0011330A (pt) 2-aril-1,2,4-triazina-3,5-di(ti)onas substituìdas
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
DE59809344D1 (de) Disubstituierte biphenyloxazoline
Pain My pet possum
ATE332647T1 (de) Verwendung von quillaja-pulver
RU2001105594A (ru) Кормовая добавка
RU96109694A (ru) Конура для домашних животных

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee